Three market changes that will impact the production of mAbs
In 2015, the monoclonal antibodies (mAbs) market was estimated to be USD 85,4 billion and [...]
How to recognize an efficient protein A resin for mAbs
In short, an efficient protein A resin is one that will not only help you [...]
How reversing downstream bioprocess steps can make all the difference
Improving the downstream bioprocess economy depends on fine-tuning an enormous range of parameters, from culture [...]
QuickTip #6: Use true buffers
A critical and fundamental factor in both analytical and preparative chromatography is the use of [...]
QuickTip #5: Filter everything
Filtering is crucial in order to protect the packed column from all solid particles in [...]
Ten things you must know when producing synthetic therapeutic peptides
Peptide therapeutic agents are enjoying increasing success but they are challenging to produce and, not [...]
Join the effort to make chromatography sustainable
The environmental impact of pharmaceutical R&D and production is considerable. Although the industry is rather [...]
Illnesses with approved monoclonal antibody therapies
As our understanding of diseases at the molecular level increases, so does the potential for [...]
QuickTip #4: yield of His-tagged proteins
Immobilized Metal Ion Affinity Chromatography (IMAC) is used for purification of His-tagged proteins. Ni-NTA based [...]
QuickTip #3: optimizing mAb purification
Designing an optimized purification process means maximizing yield and purity, and at the same time [...]
